Form 4 for CVNA Carvana
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-06 · accession 0001690820-25-000230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-09 | 2025-06-06 | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale+OE | $350.60 | -25.4K | 199.8K | -11% | -$8.91M |
| D | 2025-06-09 | 2025-06-06 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $10.07 | +25.4K | 225.2K | +13% | +$255.8K |
| D | 2025-06-09 | 2025-06-06 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $0.00 | -25.4K | 257.9K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-06 | S | D | 20,500 | $350.46 | 204,656 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). (F2) This transaction was executed in multiple trades at prices ranging from $350.00 to $350.99 inclusive. The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 2 | Common | Class A Common Stock | 2025-06-06 | S | D | 4,900 | $351.16 | 199,756 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). (F3) This transaction was executed in multiple trades at prices ranging from $351.02 to $351.20, inclusive. The price reported above reflects the volume weighted average sale price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 3 | Common | Class A Common Stock | 2025-06-06 | M | A | 25,400 | $10.07 | 225,156 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 4 | Derivative | Stock Options (Right to Buy) | 2025-06-06 | M | D | 25,400 | $0.00 | 257,886 | D | $10.07 · 2024-04-01 to 2033-02-22 | 25,400 Class A Common Stock | (F4) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2024 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |